Our Products

The same product, EVERY time.  All of our products are benchmarked for efficacy and composition and produced to the same specifications every time.

Learn more, view our products

In order to create medicines that are safe, effective and up to the standards expected of medical products, our manufacturing process is consistent, precise and subject to rigorous review. Our products are designed to satisfy and exceed the most exacting pharmaceutical standard. They are medicines that doctors can trust and incorporate into standard treatment.

The process begins with our genetics. CITIVA possesses a diverse stock of genetic strains of cannabis, each with its own cannabinoid and terpene profile. Each selected strain is grown organically without the use of pesticides or fertilizers. Each plant grown is a clone of a mother plant of a particular strain to ensure genetic consistency.

When the plants are mature they are harvested then dried and cured for a length of time determined by the desired cannabinoid content. During the process of drying and curing the cannabinoid content changes. For instance, raw cannabis has very little THC and a lot of THCA. While drying THCA converts into THC. This process happens with other cannabinoids as well.

Once the plants have been dried and cured to the proper specifications, they are moved to extraction. In order to create medical cannabis products, the medicinal oils that contain the bulk of the cannabinoid and terpene content must separate from the cellulose and other plant matter. Many companies accomplish this by using flammable solvents like alcohol and butane. At CITIVA our extraction is accomplished with food grade CO2. This creates a clean and safe product.

After extraction comes quality control. Samples are taken from the batch of oil produced. The samples are checked for contaminants and health risks. If the samples pass the rigorous safety checks they are then analyzed for cannabinoid and terpene content to ensure they match the formulations we are seeking. If the samples meet the requirements of both tests, the batch is passed on to product manufacturing where the oil is put into standardized products, such as capsules, tinctures, and oil for vaporizing using pharmaceutical grade equipment.

This process created the same product, EVERY time.  All of our products are benchmarked for efficacy and composition and produced to the very same specifications every time.

CITIVA’s product formulations are the result of evaluating years of observational research and anecdotal evidence. CITIVA does not follow the so-called “one size fits all” model with our pharmaceutical formulations. Our products are designed to treat specific indications or disease states. Each formulation contains a ratio of cannabinoids that has shown consistent effectiveness in treating a specific condition. Like typical pharmaceuticals, our formulations are developed and tested in state of the art facilities using techniques that adhere to the strictest international guidelines for nutraceutical and pharmaceutical development.

THC Level citiva Clinical Indications:
0.4 mg THC Citiva Epilepsy and other seizure disorders
THC Level citiva Clinical Indications:
3.5 mg THC Citiva Night formula: Cancer related symptoms, ALS, AIDS, Neuropathies, Insomnia, Arthritis
THC Level citiva Clinical Indications:
5 mg THC Citiva PTSD, MS, PD, IBD, Anxiety/Depression, Cancer related symptoms, Epilepsy, Arthritis
THC Level citiva Clinical Indications:
10 mg THC Citiva Fast Pain Relief, Chronic Pain, Arthritis, Neuropathies, Opiate Alternative, Cancer related symptoms
THC Level citiva Clinical Indications:
6 mg THC Citiva Day formula: Cancer, ALS, AIDS, Neuropathies, Cancer related symptoms, Arthritis
Shaping the Future of Cannabinoid Medicine
In the


View Our


Meet the